Related Experiment Video
Updated: Jun 11, 2026

An Intramedullary Locking Nail for Standardized Fixation of Femur Osteotomies to Analyze Normal and Defective Bone Healing in Mice
Published on: November 13, 2016
Nitinol in Orthopedic Applications: Clinical Insights, Performance Challenges, and Future Directions
Niyou Wang1, Veluru Jagadeesh Babu2, Namith Rangaswamy2
1Department of Mechanical Engineering, National University of Singapore, Singapore, Singapore.
None:
The increasing prevalence of spinal disorders has spurred continuous innovation in implant design and biomaterials. Among emerging options, Nitinol has gained significant interest due to its unique combination of shape memory effect, superelasticity, and mechanical compatibility with bone tissue. These characteristics make it a promising candidate for spinal implants that support minimally invasive surgery and motion preservation. This review offers a comprehensive overview of Nitinol's clinical applications in orthopedics, with a particular focus on spinal procedures. It explores key material properties, device types, and performance benefits, including reduced stress shielding and improved implant-tissue integration. A wide range of Nitinol-based devices such as screws, plates and rods, nails, artificial discs, staples, and dynamic systems are discussed alongside clinical outcomes and case studies. Emerging directions such as additive manufacturing for patient-specific implants, and smart Nitinol systems with integrated sensing or actuation capabilities are discussed. In addition, challenges in thermal control, manufacturing reproducibility, and evolving regulatory standards are addressed. By synthesizing current advancements and unmet needs, this review highlights the clinical potential of Nitinol implants and outlines future directions for their safe, effective, and scalable integration into orthopedic practice.
More Related Videos
Related Concept Videos
Local Anesthetics: Clinical Application as Spinal Anesthesia
Drug Product Performance: In Vitro–In Vivo Correlation
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

